Search research articles
Contact Us
Filters
Showing results (221-230 of 547) with videos related to
Page
of 55
Sort By:
Clinical Nutrition ESPEN
|
February 24, 2025
Developing a core outcome set for nutrition care in adult outpatients with irritable bowel syndrome (COS-RD-IBS study)
Sandra Jent, Joya Jelena Kristin Lüthi, André Meichtry, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 26, 2023
Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort Study
Michael Christian Sulz, Michael Doulberis, Nicolas Fournier, et al.
Journal of Crohn'S & Colitis
|
August 4, 2023
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies
Séverine Vermeire, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Gut
|
October 15, 2011
Role of biological therapy for inflammatory bowel disease in developing countries
Gerhard Rogler, Charles N Bernstein, Ajit Sood, et al.
Clinical Nutrition ESPEN
|
May 27, 2022
Gut microbiome and circulating bacterial DNA ("blood microbiome") in a mouse model of total parenteral nutrition: Evidence of two distinct separate microbiotic compartments
Eliana Lucchinetti, Phing-How Lou, Philipp Lemal, et al.
Journal of Crohn'S & Colitis
|
September 12, 2018
Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation
Magali Svrcek, Paula Borralho Nunes, Vincenzo Villanacci, et al.
Inflammatory Bowel Diseases
|
January 30, 2007
Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients
Tanja Spoettl, Martin Hausmann, Frank Klebl, et al.
Plos One
|
March 30, 2018
Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
Florian Kamm, Ulrike Strauch, Frauke Degenhardt, et al.
Plos One
|
September 5, 2018
Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
Florian Kamm, Ulrike Strauch, Frauke Degenhardt, et al.
Inflammatory Bowel Diseases
|
March 6, 2015
Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18
Daniela B Engler, Irina Leonardi, Mara L Hartung, et al.
Page
of 55
Search research articles
Search
Showing results (221-230 of 547) with videos related to
Sort By:
Page
of 55
Clinical Nutrition ESPEN
|
February 24, 2025
Developing a core outcome set for nutrition care in adult outpatients with irritable bowel syndrome (COS-RD-IBS study)
Sandra Jent, Joya Jelena Kristin Lüthi, André Meichtry, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 26, 2023
Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort Study
Michael Christian Sulz, Michael Doulberis, Nicolas Fournier, et al.
Journal of Crohn'S & Colitis
|
August 4, 2023
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies
Séverine Vermeire, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Gut
|
October 15, 2011
Role of biological therapy for inflammatory bowel disease in developing countries
Gerhard Rogler, Charles N Bernstein, Ajit Sood, et al.
Clinical Nutrition ESPEN
|
May 27, 2022
Gut microbiome and circulating bacterial DNA ("blood microbiome") in a mouse model of total parenteral nutrition: Evidence of two distinct separate microbiotic compartments
Eliana Lucchinetti, Phing-How Lou, Philipp Lemal, et al.
Journal of Crohn'S & Colitis
|
September 12, 2018
Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation
Magali Svrcek, Paula Borralho Nunes, Vincenzo Villanacci, et al.
Inflammatory Bowel Diseases
|
January 30, 2007
Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients
Tanja Spoettl, Martin Hausmann, Frank Klebl, et al.
Plos One
|
March 30, 2018
Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
Florian Kamm, Ulrike Strauch, Frauke Degenhardt, et al.
Plos One
|
September 5, 2018
Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
Florian Kamm, Ulrike Strauch, Frauke Degenhardt, et al.
Inflammatory Bowel Diseases
|
March 6, 2015
Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18
Daniela B Engler, Irina Leonardi, Mara L Hartung, et al.
Page
of 55